recent
identifi
interferoninduc
transmembran
protein
ifitm
inhibit
infect
divers
envelop
virus
ectop
express
restrict
grow
number
unrel
virus
includ
iav
shown
potent
restrict
infect
iav
respiratori
syncyti
viru
vivo
contrast
arenavirus
retrovirus
murin
leukemia
viru
mlv
resist
ifitm
restrict
ifitm
report
inhibit
entri
albeit
less
potent
iav
appar
cell
typedepend
manner
mechan
ifitm
inhibit
infect
divers
virus
fulli
understood
predominantli
found
late
endosom
le
lysosom
wherea
also
found
cell
peripheri
differ
membran
topolog
ifitm
propos
recent
data
suggest
type
ii
transmembran
protein
accumul
evid
impli
ifitm
may
interfer
virusendosom
fusion
fact
ifitm
seem
expand
acid
intracellular
compart
indic
fusion
block
downstream
low
ph
trigger
effect
restrict
virus
enter
le
iav
ebola
viru
ebov
sar
coronaviru
seem
consist
cellular
local
protein
howev
protein
also
restrict
vesicular
stomat
viru
vsv
appear
fuse
earli
endosom
ifitm
report
curtail
viral
infect
modifi
properti
cellular
membran
fluiditi
spontan
curvatur
effect
could
relat
part
accumul
cholesterol
le
result
ifitmmedi
disrupt
interact
vesiclemembraneproteinassoci
protein
vapa
oxysterolbind
protein
osbp
sinc
lipid
play
import
role
membran
fusion
find
offer
attract
paradigm
broad
antivir
defens
mechan
involv
alter
lipid
composit
cellular
membran
recent
find
amphotericin
b
form
complex
sterol
rescu
iav
infect
cell
line
notion
cholesterol
may
directli
indirectli
involv
iav
restrict
howev
lipid
compositionbas
model
readili
explain
lack
restrict
amphotrop
mlv
arenavirus
enter
cell
via
distinct
endocyt
rout
find
indic
ifitm
may
restrict
viru
entri
subset
intracellular
compart
order
defin
mechan
ifitm
restrict
import
identifi
viral
entri
step
target
protein
defin
compart
restrict
occur
elucid
potenti
chang
intracellular
membran
may
respons
phenotyp
examin
mechan
restrict
iav
use
singl
particl
imag
direct
viruscel
fusion
assay
result
show
inhibit
lipid
mix
stage
iav
fusion
block
releas
viral
content
cytosol
phenotyp
correl
cholesterol
accumul
intracellular
compart
specif
inhibit
convers
hemifus
fusion
mechan
reli
cholesterol
accumul
togeth
find
reveal
previous
unappreci
view
ifitmmedi
restrict
suggest
new
avenu
investig
delin
mechan
protein
block
infect
chose
focu
studi
mechan
iav
restrict
protein
potent
inhibit
infect
vitro
vivo
sinc
publish
data
suggest
like
inhibit
viral
fusion
step
direct
viruscel
fusion
assay
employ
evalu
extent
restrict
differ
cell
line
particl
carri
blamvpr
chimera
pseudotyp
influenza
ha
na
protein
strain
refer
iavpp
allow
fuse
cell
transduc
empti
vector
vector
result
cytosol
blam
activ
measur
previous
describ
sever
cell
line
test
mdck
cell
overexpress
least
permiss
iavpp
fusion
fig
agreement
previou
report
found
overexpress
partial
inhibit
vsv
g
glycoproteinmedi
fusion
pseudovirus
vsvpp
carri
blamvpr
chimera
fig
similar
inhibit
iavpp
fusion
restrict
vsvpp
potent
mdck
cell
expect
fusion
particl
pseudotyp
lassa
fever
viru
glycoprotein
lasvpp
direct
viru
entri
pathway
consider
affect
overexpress
next
check
strong
suppress
viru
fusion
mdck
cell
relat
level
express
immunostain
cho
cell
exhibit
modest
restrict
viral
fusion
fig
reveal
clear
correl
express
inhibit
iavpp
vsvpp
fusion
fig
note
potent
iav
restrict
mdck
cell
relat
usag
corebas
pseudovirus
influenza
viruslik
particl
contain
iav
chimera
also
fail
effici
fuse
cell
fuse
well
vectortransduc
cell
fig
also
found
vectortransduc
mdck
cell
highli
suscept
iav
infect
determin
viru
titrat
see
materi
method
two
cell
line
therefor
chosen
studi
restrict
describ
ifitmbas
restrict
studi
use
cellcel
fusion
model
well
forc
viral
fusion
plasma
membran
lower
ph
sinc
fusion
plasma
membran
amen
mechanist
studi
endocyt
entri
ask
whether
restrict
forc
iav
fusion
exposur
acid
buffer
induc
iavpp
fusion
cell
pretreat
bafilomycin
block
low
phdepend
entri
endosom
fig
extent
forc
fusion
lower
compar
convent
entri
rout
contrast
forc
iavpp
fusion
cell
effici
endocyt
fusion
cell
treat
low
ph
show
restrict
iavpp
fusion
cell
surfac
interestingli
suppress
iavppplasma
membran
fusion
low
ph
fig
agreement
jaagsiekt
sheep
retroviru
jsrv
iav
fusion
data
inabl
block
iav
fusion
plasma
membran
consist
lower
abund
cell
surfac
show
mechan
restrict
must
studi
intracellular
compart
preponder
evid
impli
hemifus
univers
intermedi
review
preced
format
fusion
pore
shown
overexpress
inhibit
viral
fusion
fig
c
ask
whether
protein
also
block
upstream
hemifus
step
accomplish
label
viru
membran
selfquench
concentr
vybrant
vdid
use
modif
previous
publish
protocol
incorpor
selfquench
quantiti
lipophil
dye
enabl
visual
singl
lipid
mix
event
base
mark
increas
fluoresc
upon
dye
redistribut
endosom
membran
see
exampl
significantli
control
fluctuat
vdid
fluoresc
caus
deviat
focal
plane
viral
surfac
protein
label
aminereact
dye
rel
steadi
signal
hemifus
allow
correct
vdid
intens
fluctuat
due
move
focu
colabel
protocol
modestli
reduc
iav
infect
compar
mocklabel
virus
fig
immunofluoresc
stain
virion
antiha
antibodi
reveal
excel
coloc
two
signal
fig
c
thu
support
notion
particl
bona
fide
virion
label
virus
allow
enter
cell
result
lipid
mix
activ
examin
singl
particl
track
fraction
virion
exhibit
mark
increas
vdid
signal
fig
b
redistribut
vdid
mediat
low
phdepend
conform
chang
iav
ha
glycoprotein
evidenc
potent
inhibit
lipid
mix
antiha
antibodi
fig
fig
without
simultan
monitor
viral
content
releas
cytoplasm
vdid
dequench
discrimin
hemifus
oper
defin
lipid
mix
without
content
transfer
full
fusion
avoid
overinterpret
dequench
event
refer
event
lipid
mix
hemifus
similar
vdid
dequench
pattern
observ
mdck
cell
transduc
empti
vector
data
shown
analysi
lipid
mix
show
cellbound
particl
releas
vdid
mdck
cell
respect
fig
comparison
much
greater
fraction
virion
hemifus
cho
cell
data
shown
agreement
previous
report
data
importantli
iav
lipid
mix
readili
detect
mdck
cell
fig
lipid
mix
inhibit
cell
greater
fraction
particl
releas
vdid
cell
compar
control
cell
fig
p
comparison
overexpress
mdck
cell
significantli
promot
vdid
dequench
fig
thu
contrari
cellcel
fusion
result
inhibit
even
promot
iav
lipid
mix
consist
block
viru
entri
posthemifus
stage
accordingli
addit
oleic
acid
augment
hemifus
alter
spontan
membran
curvatur
rescu
iavpp
vsvpp
fusion
cell
fig
agreement
recent
infect
result
contrast
rescu
fusion
jsrv
env
ifitmexpress
cell
fatti
acid
higher
frequenc
vdid
dequench
cell
could
caus
increas
endosom
acid
compar
control
cell
howev
distribut
wait
time
onset
lipid
mix
independ
express
type
target
cell
vs
mdck
fig
p
fact
kinet
curv
reach
plateau
indic
iav
entri
mdck
cell
complet
within
first
hour
result
thu
demonstr
restrict
iav
fusion
posthemifus
step
like
point
fusion
pore
open
evidenc
dramat
decreas
blam
signal
mdck
cell
express
protein
fig
condit
vdid
dequench
typic
complet
within
minut
control
cell
fig
dequench
rate
much
slower
sudden
increas
fluoresc
iav
membran
marker
describ
previous
portion
vdid
dequench
could
complet
within
second
fig
fast
event
common
slow
dequench
also
typic
viru
well
viru
label
excess
use
publish
protocol
singl
viru
imag
data
shown
slow
vdid
dequench
first
hour
viruscel
coincub
appear
result
iav
degrad
lelysosom
sinc
surfaceexpos
label
persist
long
vdid
dequench
complet
antiha
antibodi
block
vdid
dequench
fig
addit
detect
correl
lag
onset
lipid
mix
vdid
dequench
slope
fig
result
reinforc
notion
late
lipid
mix
event
mediat
ha
viru
degrad
control
experi
sampl
expos
laser
light
first
min
reveal
fast
dequench
event
reach
complet
less
min
data
shown
control
argu
phototoxicityrel
attenu
viru
fusogen
caus
sluggish
lipid
redistribut
sinc
free
vdid
diffus
viru
small
endosom
complet
less
second
initi
membran
connect
iav
endosom
must
sever
impair
lipid
movement
assess
whether
earli
fusion
intermedi
control
cell
restrict
vdid
diffus
extent
examin
rate
vdid
dequench
singl
particl
analysi
reveal
cell
averag
vdid
dequench
profil
fig
independ
express
initi
slope
vdid
dequench
fig
p
result
indic
overexpress
affect
properti
fusion
intermedi
respons
vdid
redistribut
size
andor
architectur
hemifus
site
eg
ask
whether
rate
vdid
dequench
vari
depend
cell
type
averag
rate
vdid
fluoresc
increas
mdck
cell
greater
cell
fig
p
demonstr
abil
detect
chang
rate
vdid
transfer
show
lipid
transfer
last
sever
minut
irrespect
cell
type
also
examin
final
extent
vdid
dequench
proport
surfac
area
target
membran
redistribut
paramet
significantli
affect
express
cell
cell
type
mdck
vs
cell
fig
togeth
similar
kinet
extent
viral
lipid
dilut
control
cell
suggest
neither
sizearchitectur
earli
fusion
intermedi
surfac
area
target
endosom
consider
affect
express
investig
relationship
lipid
mix
product
iav
infect
compar
fraction
cell
receiv
least
one
vdid
dequench
event
live
cell
imag
experi
fraction
cell
got
infect
condit
differ
viru
imag
continu
beyond
h
initi
fusion
wherea
infect
proceed
overnight
found
one
vdid
dequench
event
occur
cell
cell
got
infect
fig
condit
mdck
cell
host
one
dequench
event
infect
greater
fraction
infect
cell
compar
permiss
hemifus
like
due
shorter
time
widow
singl
viru
imag
like
miss
late
vdid
dequenc
event
fig
lower
appar
fraction
cell
support
vdid
dequench
could
also
caus
presenc
virus
incorpor
selfquench
amount
vdid
importantli
compar
effici
lipid
mix
infect
indic
former
event
like
culmin
product
infect
determin
whether
impair
iav
abil
form
small
fusion
pore
attempt
load
viru
content
marker
soak
concentr
solut
sulforhodamin
b
describ
howev
small
fraction
particl
stain
sulforhodamin
retain
dye
lost
live
cell
experi
condit
block
iav
fusion
data
shown
therefor
resort
use
hiv
pseudovirus
bear
ha
na
glycoprotein
colabel
capsid
marker
yfpvpr
content
marker
gagicherri
upon
viru
matur
intern
mcherri
proteolyt
cleav
gagicherri
releas
fusion
pore
manifest
loss
red
signal
fig
yfpvpr
signal
remain
associ
viral
core
fusion
provid
refer
signal
singl
particl
track
condit
doublelabel
pseudovirus
enter
cell
lost
content
marker
approxim
fuse
mdckvector
cell
sharp
contrast
mcherri
releas
mdck
cell
vectortransduc
cell
presenc
could
detect
fig
p
thu
advers
affect
iav
hemifus
sever
inhibit
viral
content
releas
cytoplasm
togeth
find
suggest
mechan
restrict
aris
entrap
virus
hemifus
intermedi
prior
fusion
pore
format
recent
studi
shown
disrupt
interact
vapa
osbp
caus
cholesterol
accumul
le
base
find
author
propos
high
level
endosom
cholesterol
may
inhibit
iav
fusion
andor
releas
nucleocapsid
stain
filipin
reveal
cell
exhibit
increas
level
intracellular
cholesterol
fig
howev
filipin
signal
still
primarili
associ
plasma
membran
total
cellular
cholesterol
elev
cell
fig
addit
overal
intens
intracellular
cholesterol
poorli
correl
level
express
fig
comparison
pretreat
cell
inhibit
transport
ldlderiv
cholesterol
lelysosom
review
result
dramat
shift
filipin
stain
pattern
plasma
membran
endosom
fig
aberr
accumul
cholesterol
le
also
known
occur
cell
lack
function
cholesterol
transport
therefor
knock
express
cell
use
shrna
fig
examin
result
cholesterol
distribut
fig
reduc
express
correl
excess
cholesterol
intracellular
compart
also
much
pronounc
endosom
filipin
stain
cell
next
ask
whether
cholesterol
accumul
induc
pretreat
regul
phenocopi
restrict
viral
fusion
neither
iav
lipid
mix
vdid
dequench
fusion
blam
signal
inhibit
silenc
cell
fig
f
vsvpp
also
fuse
cell
effici
control
cell
fig
result
show
excess
cholesterol
inhibit
viral
fusion
hemifus
control
experi
silenc
express
potent
suppress
fusion
ebola
gppseudotyp
particl
ebovpp
fig
use
receptor
similar
knockdown
phenotyp
pretreat
cell
caus
cholesterol
buildup
endosom
fig
inhibit
fusion
iavpp
vsvpp
fig
shown
mdck
cell
higher
dose
inhibit
viral
fusion
fig
effect
due
elev
endosom
ph
oppos
cholesterol
accumul
endosom
gener
effect
excess
cholesterol
cell
test
whether
endosom
cholesterol
inhibit
viral
fusion
mdck
cell
cell
overexpress
mdck
cell
caus
moder
accumul
cholesterol
endosom
fig
pretreat
caus
much
dramat
buildup
intracellular
cholesterol
fig
howev
unlik
cell
iavpp
vsvpp
fusion
significantli
inhibit
mdck
cell
fig
sinc
prolong
exposur
report
rais
endosom
ph
sought
determin
insuffici
acid
ph
could
prevent
iav
hemifusionfus
pretreat
mdck
cell
ph
iavcarri
endosom
measur
use
virion
colabel
phinsensit
green
red
fluoresc
brighter
acid
ph
fig
cell
incub
virus
min
redgreen
signal
ratio
individu
particl
measur
fig
averag
ph
viruscontain
endosom
cell
slightli
less
acid
control
cell
n
vs
n
respect
fig
f
p
interestingli
shown
figur
endosom
ph
mdck
cell
markedli
shift
neutral
valu
n
p
sinc
ph
threshold
trigger
fusion
report
around
elev
endosom
ph
mdck
cell
like
caus
inhibit
viral
fusion
togeth
result
impli
like
attenu
iav
fusion
mdck
cell
rais
endosom
ph
induc
cholesterol
accumul
also
took
advantag
avail
cho
cell
line
express
ascertain
role
endosom
cholesterol
iav
fusion
cell
design
exhibit
exagger
endosom
cholesterol
stain
sharp
contrast
peripher
stain
pattern
parent
cho
cell
fig
spite
high
endosom
cholesterol
content
cell
elev
level
total
cholesterol
fig
iavpp
fuse
cell
effici
parent
cell
fig
cell
also
support
iav
lipid
mix
albeit
somewhat
reduc
level
compar
control
fig
pretreat
cho
cell
also
trap
cholesterol
endosom
rais
total
cholesterol
content
fig
modestli
diminish
extent
iavpp
vsvpp
fusion
fig
interestingli
contrast
decreas
endosom
acid
mdck
cell
endosom
cho
cell
acid
control
cell
fig
control
experi
lack
express
pretreat
block
ebovpp
fusion
fig
e
consist
relianc
receptor
high
sensit
disrupt
cholesterol
transport
togeth
result
show
cholesterol
accumul
achiev
two
differ
intervent
pretreat
silenc
phenocopi
restrict
viral
fusion
impli
elev
level
endosom
cholesterol
gener
confer
resist
viral
fusion
ii
mechan
block
transit
hemifus
full
fusion
misloc
cholesterol
ifitm
restrict
cellular
entri
multipl
pathogen
envelop
virus
recent
studi
lead
model
ifitm
inhibit
virushost
hemifus
membranerigidifi
properti
cholesterol
may
contribut
antivir
action
contrast
studi
result
demonstr
prevent
releas
viral
genom
cytosol
inhibit
viral
entri
hemifus
prior
fusion
pore
format
fig
moreov
found
promot
hemifus
cell
perhap
secondari
acidifi
endosom
pathway
therefor
neg
regul
properti
contact
leaflet
involv
hemifus
stabil
cytoplasm
leaflet
endosom
membran
therebi
disfavor
format
fusion
pore
one
potenti
scenario
locat
directli
site
arrest
hemifus
perhap
toughen
endosom
membran
creat
barrier
viral
entri
pathway
consider
coloc
intern
iav
fig
consist
pathway
direct
mechan
inhibit
altern
might
arrest
hemifus
indirect
mechan
perhap
involv
modul
lipid
andor
protein
composit
cytoplasm
leaflet
pathway
recent
find
chang
global
membran
properti
interfer
product
entri
would
appear
support
indirect
mechan
lipid
unsatur
fatti
acid
cholesterol
confer
neg
spontan
curvatur
membran
promot
hemifus
net
neg
curvatur
structur
disfavor
fusion
pore
net
posit
curvatur
intermedi
previous
shown
oleic
acid
although
predict
consist
effici
lipid
mix
endosom
cell
observ
imag
experi
sever
studi
result
support
cholesterol
accumul
play
role
fusion
inhibit
found
cholesterolladen
endosom
cell
pretreat
express
undetectablelow
level
support
effici
viral
fusion
thu
possibl
interfer
cellular
function
vapa
interact
osbp
regul
snare
modul
later
mobil
membran
protein
review
appear
induc
format
multivesicular
bodi
increas
number
ilv
one
therefor
envis
may
inhibit
infect
redirect
virus
nonproduct
pathway
perhap
involv
fusion
ilv
instead
limit
membran
le
fig
pathway
suggest
disallow
back
fusion
ilv
limit
membran
virusilv
fusion
product
like
degrad
inde
back
fusion
implic
vsv
core
releas
cytosol
follow
virusilv
fusion
stress
fusion
decoy
model
explain
abil
interfer
fusion
cell
surfac
fig
also
clear
old
world
arenavirus
report
enter
mvb
restrict
ifitm
indistinguish
extent
vdid
dequench
control
cell
fig
indic
target
endosom
similar
size
appear
argu
redirect
iav
fusion
small
ilv
lack
posthemifus
decay
vdid
fluoresc
mdck
cell
fig
consist
iav
fusion
abund
ilv
endosom
cell
lipophil
dye
limit
membran
endosom
quickli
remov
membran
traffick
postdequench
decay
observ
irrespect
level
express
possibl
iav
may
infect
sever
cell
line
fuse
small
intralumen
vesicl
follow
nucleocapsid
releas
back
fusion
fig
dash
black
arrow
pathway
could
explain
similar
extent
rate
vdid
dequench
control
cell
indic
similar
lipid
intermedi
size
target
membran
respect
discuss
slow
vdid
dequench
observ
singl
iav
imag
ration
context
fusion
limit
membran
endosom
pathway
well
context
fusion
ilv
pathway
slow
dilut
dye
pathway
could
occur
multipl
round
iav
fusion
small
ilv
wherea
pathway
would
predict
restrict
lipid
diffus
earli
fusion
intermedi
form
limit
membran
although
latter
notion
agreement
report
restrict
lipid
movement
hemifus
site
small
fusion
pore
intermedi
usual
shortliv
physiolog
condit
tend
resolv
larger
structur
impair
lipid
movement
clearli
detail
studi
virusendosom
hemifus
fusion
need
understand
natur
slow
lipid
redistribut
iav
endosom
ifitm
may
arguabl
one
broadli
act
clinic
relev
restrict
factor
famili
membraneassoci
topolog
local
site
viral
attenu
suggest
act
restrict
viral
entri
via
direct
mechan
addit
work
remain
done
fulli
elucid
action
nonetheless
primari
effector
ifn
antiiav
action
repres
previous
unappreci
class
restrict
factor
prevent
viral
entri
stabil
hemifus
intermedi
like
compris
invad
viru
fatal
tether
interior
endosom
limit
membran
futur
singl
viru
experi
combin
detect
viral
lipid
content
releas
event
see
exampl
provid
insight
iav
entri
pathway
mechan
restrict
inde
effort
may
also
bring
light
unknown
viral
countermeasur
perhap
employ
ifitmresist
new
old
world
arenavirus
hek
cell
human
lung
epitheli
cell
obtain
atcc
manassa
va
grown
previous
describ
wildtyp
cho
cell
cell
gift
dr
l
liscum
tuft
univers
grown
alphamem
qualiti
biolog
inc
gaithersburg
md
supplement
fb
penicillinstreptomycin
mdck
cho
cell
stabli
express
obtain
transduc
vsvgpseudotyp
virus
encod
wildtyp
vector
pqcxip
clontech
select
puromycin
describ
previous
blamvpr
pcrev
pmdg
vsv
g
express
vector
describ
previous
yfpvpr
gift
dr
hope
northwestern
univers
pcagg
vector
encod
influenza
wsn
ha
na
provid
donna
tscern
peter
pales
pcagg
wsn
plasmid
gift
dr
garciasastr
mount
sinai
vector
express
phcmvgpc
lassa
gp
zair
gift
dr
fl
cosset
de
lyon
franc
dr
l
rong
univers
illinoi
respect
tocri
bioscienc
bristol
uk
polyllysin
filipin
sulphorhodamin
b
bafilomycin
cholesterol
kit
sigmaaldrich
aminereact
carboxyl
acid
vybrantdid
vdid
salt
live
cell
imag
buffer
purchas
life
technolog
grand
island
ny
mono
nh
ester
ge
healthcar
pittsburgh
pa
antibodi
use
rabbit
nterminu
abgent
san
diego
ca
mous
antiiavnp
goat
antiiavpolyclon
antibodi
millipor
billerica
rat
antimouseiggfitc
ebiosci
san
diego
ca
goat
jackson
immunoresearch
west
grove
pa
pseudoviru
product
titrat
describ
previous
pseudovirus
produc
transfect
cell
use
jetprim
transfect
reagent
polyplustransfect
sa
ny
lasv
ebov
pseudovirus
phcmvgpc
lassa
gp
includ
transfect
mixtur
fluoresc
label
influenza
pseudovirus
produc
use
yfpvpr
pcrev
wsn
ha
naexpress
vector
ebola
gp
pseudovirus
concentr
use
concentr
clontech
mountain
view
ca
gener
influenza
vlp
cell
transfect
pcaggswsn
ha
pcaggswsn
na
h
transfect
reagent
remov
cell
cultiv
phenol
redfre
growth
medium
influenza
viru
surfac
protein
lipid
membran
label
vdid
respect
hundr
influenza
viru
purifi
stock
mgml
charl
river
ct
dilut
sodium
bicarbon
buffer
ph
supplement
mixtur
incub
min
room
temperatur
time
vdid
mm
stock
dmso
ad
follow
addit
incub
min
dark
room
temperatur
mild
agit
label
virus
purifi
gel
filtrat
column
ge
healthcar
mm
nacl
solut
buffer
mm
hepe
ph
approxim
particl
incorpor
detect
amount
vdid
minim
contamin
free
dye
aggreg
infecti
iav
titer
determin
mdck
cell
incub
serial
dilut
inoculum
h
cell
fix
permeabil
block
incub
rabbit
antiwsn
ha
antibodi
gift
dr
steinhauer
emori
univers
h
room
temperatur
cell
wash
incub
secondari
goat
antirabbit
antibodi
jackson
immunoresearch
pa
fbscontain
buffer
supplement
h
number
infect
cell
per
imag
field
determin
fluoresc
microscopi
normal
total
number
cell
stain
nuclei
infecti
titer
iuml
calcul
take
account
ratio
area
well
imag
area
correct
dilut
volum
viral
inoculum
blam
assay
viruscel
fusion
carri
describ
previous
method
briefli
pseudovirus
bear
chimera
blamvpr
bound
target
cell
centrifug
min
unbound
virus
remov
wash
fusion
initi
shift
min
time
cell
place
ice
load
substrat
life
technolog
cytoplasm
blam
activ
ratio
blue
green
fluoresc
measur
overnight
incub
use
synergi
ht
fluoresc
micropl
reader
biotek
germani
iav
prebound
cell
cold
follow
incub
min
immunostain
mous
antiiavnp
millipor
billerica
applic
rabbit
antibodi
nterminu
abgent
san
diego
ca
describ
rat
antimouseiggfitc
ebiosci
san
diego
ca
goat
antibodi
use
secondari
stain
cellular
distribut
cholesterol
examin
incub
mgml
filipin
ad
incub
secondari
antibodi
imag
collect
lsm
laser
scan
microscop
carl
zeiss
germani
use
oil
immers
object
stain
method
involv
fixat
paraformaldehyd
permeabil
block
fb
dilut
phosphat
buffer
salin
calcium
magnesium
sequenti
incub
primari
secondari
antibodi
h
h
respect
silenc
gene
cell
transduc
five
shrna
encod
lentivir
vector
sigma
select
puromycin
sampl
western
blot
process
describ
protein
band
detect
rabbit
abcam
cambridg
horseradish
peroxidaseconjug
protein
g
biorad
hercul
ca
use
chemiluminesc
reagent
ge
healthcar
cell
grown
glassbottom
petri
dish
mattek
chill
ice
wash
cold
hank
balanc
salt
solut
hbss
predetermin
amount
viral
suspens
ad
cell
spinocul
min
cell
wash
twice
cold
hbss
place
stage
lsm
confoc
microscop
viru
entri
initi
ad
ml
prewarm
imag
buffer
imag
use
capo
waterimmers
object
three
zstack
separ
acquir
everi
multitim
macro
carl
zeiss
block
iav
hemifus
fusion
experi
perform
hbss
supplement
mm
mm
ph
contain
nm
time
laps
imag
first
visual
inspect
identifi
vdid
dequench
loss
mcherri
event
number
relev
event
experi
independ
determin
two
train
individu
particl
trajectori
meantot
fluoresc
intens
obtain
use
voloc
perkinelm
onset
lipid
mix
initi
slope
vdid
dequench
determin
fit
pair
straight
line
fig
iav
particl
colabel
dye
phinsensit
fluoresc
brighter
acid
ph
ratio
signal
convert
ph
valu
use
calibr
curv
obtain
expos
coverslipimmobil
virus
citratephosph
buffer
differ
acid
fig
imag
collect
differ
field
sum
singleparticl
fluoresc
calcul
mean
ratio
signal
function
ph
use
calibr
curv
cell
inocul
label
virus
min
describ
imag
collect
least
differ
field
singl
particlebas
ratio
fluoresc
signal
calcul
outlier
nearbackground
signal
reject
reduc
uncertainti
ph
measur
statist
signific
assess
use
pairwis
ttest
rank
sum
test
singleparticl
fusion
event
control
express
cell
compar
ztest
